In Patients With Type 1 Diabetes and Proteinuria Sustained Reduction of Glycemia Prevents Risk of End-Stage Renal Disease

被引：0
|
作者：
Skupien, Jan
Warram, James D.
Smiles, Adam M.
Galecki, Andrzej T.
Stanton, Robert C.
Krolewski, Andrzej S.
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
552-P
引用
收藏
页码：A140 / A140
页数：1
相关论文
共 50 条
  • [41] Risk of Band Keratopathy in Patients with End-Stage Renal Disease
    Weng, Shih-Feng
    Jan, Ren-Long
    Chang, Chun
    Wang, Jhi-Joung
    Su, Shih-Bin
    Huang, Chien-Cheng
    Tseng, Sung-Huei
    Chang, Yuh-Shin
    SCIENTIFIC REPORTS, 2016, 6
  • [42] Early-Onset Type 2 Diabetes as a Risk Factor for End-Stage Renal Disease in Patients With Diabetic Kidney Disease
    Zheng, Li
    Chen, Xiangjun
    Luo, Ting
    Ran, Xi
    Hu, Jinbo
    Cheng, Qingfeng
    Yang, Shumin
    Wu, Jinshan
    Li, Qifu
    Wang, Zhihong
    PREVENTING CHRONIC DISEASE, 2020, 17
  • [43] Predicting End-Stage Kidney Disease in Type 1 Diabetes
    Vistisen, Dorte
    Andersen, Gregers S.
    Hulman, Adam
    Mcgurnaghan, Stuart
    Colhoun, Helen M.
    Henriksen, Jan Erik
    Thomsen, Reimar W.
    Persson, Frederik
    Rossing, Peter
    Jorgensen, Marit E.
    DIABETES, 2020, 69
  • [44] Prevalence of cardiovascular risk factors in patients with type 1 diabetes in end-stage renal disease: changes in the trend from 1999 to 2006
    Rueda, Sergio F.
    Fernandez, Cristian
    Nicolau, Joana
    Ricart, Maria J.
    Esmatjes, Enric
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2009, 23 (05) : 317 - 322
  • [45] Serum transferrin predicts end-stage Renal Disease in Type 2 Diabetes Mellitus patients
    Zhao, Lijun
    Zou, Yutong
    Zhang, Junlin
    Zhang, Rui
    Ren, Honghong
    Lin, Li
    Guo, Ruikun
    Zhang, Jie
    Liu, Fang
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (14): : 2113 - 2124
  • [46] Cumulative Risk of End-Stage Renal Disease Among Patients With Type 2 Diabetes: A Nationwide Inception Cohort Study
    Finne, Patrik
    Groop, Per-Henrik
    Arffman, Martti
    Kervinen, Marjo
    Helve, Jaakko
    Gronhagen-Riska, Carola
    Sund, Reijo
    DIABETES CARE, 2019, 42 (04) : 539 - 544
  • [47] The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus
    Postma, Maarten J.
    de Zeeuw, Dick
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (10) : 2975 - 2983
  • [48] Efficacy of Saxagliptin versus Mitiglinid in patients with type 2 diabetes and end-stage renal disease
    Sakai Y.
    Sakai S.
    Mugishima K.
    Katayama A.
    Sumi Y.
    Otsuka Y.
    Otsuka T.
    Tsuruoka S.
    Renal Replacement Therapy, 3 (1)
  • [49] The impact of glycaemic control on outcomes in patients with end-stage renal disease and type 2 diabetes
    Zoungas, Sophia
    Kerr, Peter G.
    Lui, Michelle
    Teede, Helena J.
    NEPHROLOGY, 2008, 13 (02) : 124 - 127
  • [50] IMPACT OF DIABETES MELLITUS ON THE RISK OF END-STAGE RENAL DISEASE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Ghafoor, Rabbiya
    Khan, Mehran
    Zaman, Abhar
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (06): : 5665 - 5669
12345